US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Alexium International Group Ltd (PK) (AXIIF) 銘柄情報

Alexium International Group Ltd (PK) (AXIIF)

0.002

0.00

(0.00%)

終了 6月6日 5:00AM

Alexium International Group Ltd (PK) (AXIIF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.002

( - )

買値

0.0011

売値

0.002

出来高

-

0.00 日の範囲 0.00

0.0008 52 週間の範囲 0.002

時価総額

前日終値

0.002

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 275,365

発行済株式数

3,127,784,951

配当利回り

PER

-1.88

1 株当たり利益 (EPS)

-0

歳入

3.42M

純利益

-4.37M

Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural an... Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the cooling experience; and DelCool, a thermal management product. The company also provides flame retardant solutions, including Alexiflam, a flame-retardant treatment for cotton and cellulose-based textiles; AlexiGuard, a flame-retardant emulsion tailored for 100% polyester fabric; and AlexiShield, a water-resistant flame-retardant solution for providing enhanced flame resistance in mattresses. It serves bedding, body armour, military uniform, and workwear markets. The company is headquartered in Greer, South Carolina. 詳細を表示

セクター

Materials

業界

Chemicals

ウェブサイト

www.alexiuminternational.com

本社

Greer, United States

設立

-

Alexium International Group Ltd (PK) is listed in the Materials sector of the その他OTC with ticker AXIIF. The last closing price for Alexium (PK) was US$0. Over the last year, Alexium (PK) shares have traded in a share price range of US$ 0.0008 to US$ 0.002.

Alexium (PK) currently has 3,127,784,951 shares in issue. The market capitalisation of Alexium (PK) is US$6.26 million. Alexium (PK) has a price to earnings ratio (PE ratio) of -1.88.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.002	0.002	0.002	20500	0.002	CS
26	0.0012	150	0.0008	0.002	0.0008	10250	0.002	CS
52	0.0012	150	0.0008	0.002	0.0008	4316	0.002	CS
156	0.0012	150	0.0008	0.002	0.0008	3154	0.002	CS
260	-0.0436	-95.6140350877	0.0456	0.1	0.0005	9936	0.01874353	CS

AXIIF - Frequently Asked Questions (FAQ)

What is the current Alexium International Group Ltd (PK) share price?

The current share price of Alexium International Group Ltd (PK) is US$ 0.002

How many Alexium International Group Ltd (PK) shares are in issue?

Alexium International Group Ltd (PK) has 3,127,784,951 shares in issue

What is the market cap of Alexium International Group Ltd (PK)?

The market capitalisation of Alexium International Group Ltd (PK) is USD 6.26M

What is the 1 year trading range for Alexium International Group Ltd (PK) share price?

Alexium International Group Ltd (PK) has traded in the range of US$ 0.0008 to US$ 0.002 during the past year

What is the PE ratio of Alexium International Group Ltd (PK)?

The price to earnings ratio of Alexium International Group Ltd (PK) is -1.88

What is the cash to sales ratio of Alexium International Group Ltd (PK)?

The cash to sales ratio of Alexium International Group Ltd (PK) is 4.6

What is the registered address of Alexium International Group Ltd (PK)?

The registered address for Alexium International Group Ltd (PK) is 350 West Phillips Road, Greer, South Carolina, 29650

What is the Alexium International Group Ltd (PK) website address?

The website address for Alexium International Group Ltd (PK) is www.alexiuminternational.com

Which industry sector does Alexium International Group Ltd (PK) operate in?

Alexium International Group Ltd (PK) operates in the Chemicals sector

US Market News

US Market News 6分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 7分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 8分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 11分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 13分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 15分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 16分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 16分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 19分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 20分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 20分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 22分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 23分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 24分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 24分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 24分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 25分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 26分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 26分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 27分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 29分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 32分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

International Battery Me... (QB)

BNP Paribas 2.75% 27jan2...

Amundi 500D iNav

Bpce5.41%26sep38 Bpce5.4...

Taiyo Yuden (PK)

Callable Accreting Notes...

Adams Street 2012 Emergi...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。